Apollo Hospitals Enterprise Limited - healthcare in Chennai, Tamil Nadu, India. FY 2026 financials and compliance.
CIN L85110TN1979PLC008035 Incorporated 05 December 1979 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Listed - NSE: APOLLOHOSP · BSE: 508869 Public Limited Company healthcare
Data last updated
Revenue · FY 2026
₹25,229 Cr
▲ 15.76% YoY
Computed EBITDA · FY 2026
₹3,960.9 Cr
▲ 22.93% YoY
Net profit · FY 2026
₹2,002.7 Cr
▲ 33.06% YoY
Authorised capital
₹110 Cr
Registered with MCA
Paid-up capital
₹71.89 Cr
Issued & subscribed
Open charges
₹3,978.73 Cr
Satisfied ₹5,997.95 Cr
Company age
47 yrs
Est. 1979
Employees · EPFO
24,811
Latest available

About Apollo Hospitals Enterprise Limited

Data last updated: 14 July 2026

Apollo Hospitals Enterprise Limited is a public limited company based in Chennai, Tamil Nadu, India. It specialises in hospital and clinical services, a part of the broader healthcare sector. Incorporated on 05 December 1979, the company has been in operation for over 47 years.

Registered with ROC Chennai under CIN L85110TN1979PLC008035. Listed on BSE: 508869 and NSE: APOLLOHOSP.

Capital: an authorised share capital of ₹110 Cr and a paid-up capital of ₹71.89 Cr. It is led by directors including Pratap Chandra Reddy and Shobana Kamineni.

Last AGM: 29 August 2025. Financial statements filed for year ended 31 March 2025. Office: 19 Bishop Gardens R A Puram, Chennai, Tamil Nadu, India – 600028.

As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹25,229 Cr, a growth of 15.76% compared to the previous year. The net worth stands at ₹9,974.5 Cr (up 15.27% YoY). Total assets are valued at ₹22,197 Cr (up 7.45% YoY).

The company has a workforce of approximately 24,811 employees as per the latest available data. Its group structure includes 34 subsidiaries and 2 joint ventures.

The company is associated with 7 brands, including Apollo Gleneagles Hospitals, Ask Apollo, Apollo Hospitals Bangalore, Apollo Health And Lifestyle, Apollo Hospitals among others. As per MCA filings, the company has open charges of ₹3,978.73 Cr and satisfied charges of ₹5,997.95 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website apollohospitals.com.

Company Details of Apollo Hospitals Enterprise Limited
CIN L85110TN1979PLC008035
Registration Number 008035
Incorporation Date 05 December 1979
ROC Chennai
Listing Status Listed (BSE: 508869, NSE: APOLLOHOSP)
Company Status Active
Date of Last AGM 29 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    19 Bishop Gardens R A Puram, Chennai, Tamil Nadu, India – 600028
  • Industry
    Healthcare, Hospitals
Company report
Apollo Hospitals Enterprise Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Apollo Hospitals Enterprise Limited report

Financials, compliance, directors, charges, ownership and filings for Apollo Hospitals Enterprise Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Apollo Hospitals Enterprise Limited

Apollo Hospitals Enterprise Limited operates multiple associated brands including Apollo Gleneagles Hospitals, Ask Apollo, and Apollo Hospitals Bangalore. These brands represent Apollo Hospitals Enterprise Limited's diversified market presence and brand portfolio.

Brand Description Website
Operates a chain of multispeciality hospitals offering comprehensive care. apollogleneagles.in
Offers a telemedicine platform provided by Apollo Hospital for remote consultations. askapollo.com
A chain of multi-speciality hospitals is operated in India. apollohl.com
Chain of multispecialty hospitals apollohospitals.com
Online pharmacy with doctor consultations and appointment bookings is provided. apollo247.com
Chain of multispeciality hospitals apollobsr.com
Health care services, medical treatments, and informational articles focused on various conditions in Bangalore. apollohospitalsbangalore.com

Competitors & Alternatives of Apollo Hospitals Enterprise Limited

Brands and companies operating in the same space as Apollo Hospitals Enterprise Limited include MediBuddy, KIMS Hospitals, CureBay and 7 more.

Competitor Description Location Founded
MediBuddy MediBuddy Online platform offering multiple healthcare services Bengaluru, India, India 2013
KIMS Hospitals KIMS Hospitals Multispeciality secondary and tertiary care is provided by hospital chains. Secunderabad, India, India 1999
CureBay CureBay Healthcare services are delivered via an online platform. Bhubaneswar, India, India 2020
Practo Practo Doctor appointments are booked and healthcare professionals are consulted online. Bengaluru, India, India 2008
Fortis Healthcare Fortis Healthcare Multi-specialty hospital services are provided across India by Fortis Healthcare. Gurugram, India, India 1996
Ujala Cygnus Ujala Cygnus A chain of multi-specialty hospitals is operated in India. Delhi, India, India 2011
Kauvery Hospital Kauvery Hospital Chain of multi-speciality hospitals Chennai, India, India 1999
CallHealth CallHealth Integrated at-home healthcare services, including tele-consultation and diagnostics, are provided. Hyderabad, India, India 2013
API Holdings API Holdings Digital healthcare tools are offered for pharmacies and clinics management. Mumbai, India, India 2012
Sahyadri Hospitals Sahyadri Hospitals Multi-speciality hospitals are operated with diverse medical services in India. Pune, India, India 1994

Business Activity of Apollo Hospitals Enterprise Limited

Apollo Hospitals Enterprise Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including hospital activities.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
Q Hospital and Medical Care Q1 Hospital activities Locked
Premium access

Business activity turnover details for Apollo Hospitals Enterprise Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Apollo Hospitals Enterprise Limited

Apollo Hospitals Enterprise Limited is audited by DELOITTE HASKINS & SELLS LLP (ICAI peer reviewed, certificate valid till 2027-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
DELOITTE HASKINS & SELLS LLP (ICAI peer reviewed, certificate valid till 2027-07-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Apollo Hospitals Enterprise Limited

Apollo Hospitals Enterprise Limited is currently managed by 10 directors, with 24 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Pratap Chandra Reddy Whole-Time Director 05 Dec 1979 46 Years 7 Months Current
Shobana Kamineni Director 02 Jul 2014 12 Years 0 Months Current
Konda Sangita Reddy Whole-Time Director 03 Feb 2011 15 Years 5 Months Current
Pudugramam Murali Doraiswamy Director 27 Sep 2018 7 Years 9 Months Current
Velagapudi Kavitha Dutt Director 09 Feb 2019 7 Years 5 Months Current
Bhaskara Mandavilli Nageswara Rao Director 09 Feb 2019 7 Years 5 Months Current
Showing 6 of 10 current directors. View all directors

Financials of Apollo Hospitals Enterprise Limited FY 2026 filings available

Apollo Hospitals Enterprise Limited reported revenue of ₹25,229 Cr (up 15.76% YoY) for FY 2026.

Revenue · FY 2026
₹25,229 Cr ▲ 15.76%
Profit · FY 2026
₹2,002.7 Cr ▲ 33.06%
Computed EBITDA · FY 2026
₹3,960.9 Cr ▲ 22.93%
Revenue₹ Cr · Consolidated010,00020,00030,000FY 2020: ₹11,247 Cr11,247FY 2020FY 2021: ₹10,560 Cr · -6.1% YoY10,560-6.1%FY 2021FY 2022: ₹14,663 Cr · +38.9% YoY14,663+38.9%FY 2022FY 2023: ₹16,612 Cr · +13.3% YoY16,612+13.3%FY 2023FY 2024: ₹19,059 Cr · +14.7% YoY19,059+14.7%FY 2024FY 2025: ₹21,794 Cr · +14.3% YoY21,794+14.3%FY 2025FY 2026: ₹25,229 Cr · +15.8% YoY25,228+15.8%FY 2026
Net Profit₹ Cr · Consolidated01,0002,0003,000FY 2020: ₹432 Cr432FY 2020FY 2021: ₹137 Cr · -68.3% YoY137-68.3%FY 2021FY 2022: ₹1,108 Cr · +710.4% YoY1,108+710.4%FY 2022FY 2023: ₹845 Cr · -23.8% YoY845-23.8%FY 2023FY 2024: ₹935 Cr · +10.7% YoY935+10.7%FY 2024FY 2025: ₹1,505 Cr · +61% YoY1,505+61%FY 2025FY 2026: ₹2,003 Cr · +33.1% YoY2,003+33.1%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year02,5005,0007,500Q1'25: ₹5,086 Cr · +15.1% YoY5,086+15.1%Q1'25Q2'25: ₹5,589 Cr · +15.3% YoY5,589+15.3%Q2'25Q3'25: ₹5,527 Cr · +13.9% YoY5,527+13.9%Q3'25Q4'25: ₹5,592 Cr · +13.1% YoY5,592+13.1%Q4'25Q1'26: ₹5,842 Cr · +14.9% YoY5,842+14.9%Q1'26Q2'26: ₹6,304 Cr · +12.8% YoY6,304+12.8%Q2'26Q3'26: ₹6,477 Cr · +17.2% YoY6,477+17.2%Q3'26Q4'26: ₹6,606 Cr · +18.1% YoY6,606+18.1%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹25,229 Cr ₹21,794 Cr ₹19,059 Cr ₹16,612 Cr ₹14,663 Cr ₹10,560 Cr ₹11,247 Cr
Other Income ₹191.6 Cr ₹200.3 Cr ₹106.3 Cr ₹90.34 Cr ₹78.14 Cr ₹44.99 Cr ₹26.97 Cr
Total Income ₹25,420 Cr ₹21,994 Cr ₹19,166 Cr ₹16,703 Cr ₹14,741 Cr ₹10,605 Cr ₹11,274 Cr
Cost of Materials Consumed ₹3,040.8 Cr ₹2,754.4 Cr ₹2,454.1 Cr ₹2,283.77 Cr ₹2,685.48 Cr ₹1,623.31 Cr ₹1,809.23 Cr
Purchases of Stock-in-Trade ₹10,056 Cr ₹8,556.7 Cr ₹7,384.9 Cr ₹6,315 Cr ₹4,961.33 Cr ₹4,186.06 Cr ₹3,796.67 Cr
Changes in Inventories -₹21.6 Cr -₹1.1 Cr -₹33.5 Cr -₹24.54 Cr -₹73.34 Cr -₹125.17 Cr -₹107.03 Cr
Employee Benefit Expense ₹3,000.3 Cr ₹2,769.2 Cr ₹2,493.7 Cr ₹2,143.78 Cr ₹1,786.52 Cr ₹1,600.97 Cr ₹1,852.92 Cr
Finance Costs ₹449.6 Cr ₹458.5 Cr ₹449.4 Cr ₹380.79 Cr ₹378.64 Cr ₹449.22 Cr ₹532.77 Cr
Depreciation & Amortisation ₹876.1 Cr ₹757.5 Cr ₹687 Cr ₹615.24 Cr ₹600.7 Cr ₹573.13 Cr ₹619.69 Cr
Other Expenses ₹5,383.3 Cr ₹4,693 Cr ₹4,369.3 Cr ₹3,844.83 Cr ₹3,117.53 Cr ₹2,137.43 Cr ₹2,307.72 Cr
Total Expenses ₹22,785 Cr ₹19,988 Cr ₹17,805 Cr ₹15,559 Cr ₹13,457 Cr ₹10,445 Cr ₹10,812 Cr
Profit Before Exceptional Items & Tax ₹2,635.2 Cr ₹2,006.1 Cr ₹1,360.6 Cr ₹1,143.92 Cr ₹1,283.92 Cr ₹160.05 Cr ₹461.8 Cr
Exceptional Items -₹19.2 Cr ₹0 ₹1.9 Cr ₹0 ₹294.11 Cr ₹60.65 Cr ₹198.3 Cr
Profit Before Tax ₹2,616 Cr ₹2,006.1 Cr ₹1,362.5 Cr ₹1,143.92 Cr ₹1,578.03 Cr ₹220.7 Cr ₹660.1 Cr
Total Tax Expense ₹658.2 Cr ₹534 Cr ₹445.5 Cr ₹256.2 Cr ₹477.02 Cr ₹84.7 Cr ₹225.19 Cr
Net Profit ₹2,002.7 Cr ₹1,505.1 Cr ₹935 Cr ₹844.57 Cr ₹1,108.36 Cr ₹136.77 Cr ₹431.8 Cr
  attributable to Owners ₹1,941.7 Cr ₹1,445.9 Cr ₹898.6 Cr ₹819.07 Cr ₹1,055.61 Cr ₹150.36 Cr ₹454.94 Cr
  attributable to NCI ₹61 Cr ₹59.2 Cr ₹36.4 Cr ₹25.5 Cr ₹52.75 Cr -₹13.6 Cr -₹23.14 Cr
Other Comprehensive Income ₹58.4 Cr -₹6.3 Cr -₹10.4 Cr -₹13.27 Cr -₹9.72 Cr ₹15.33 Cr -₹60 Lakh
Total Comprehensive Income ₹2,061.1 Cr ₹1,498.8 Cr ₹924.6 Cr ₹831.3 Cr ₹1,098.64 Cr ₹152.1 Cr ₹431.2 Cr
EBITDA (computed) ₹3,960.9 Cr ₹3,222.1 Cr ₹2,497 Cr ₹2,139.95 Cr ₹2,263.26 Cr ₹1,182.4 Cr ₹1,614.26 Cr
Basic EPS ₹135.04 ₹100.56 ₹62.50 ₹56.97 ₹73.42 ₹10.74 ₹32.70
Diluted EPS ₹134.94 ₹100.56 ₹62.50 ₹56.97 ₹73.42 ₹10.74 ₹32.70
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹22,197 Cr ₹20,657 Cr ₹16,753 Cr ₹14,428 Cr
Non-current Assets ₹15,297 Cr ₹13,629 Cr ₹11,473 Cr ₹10,091 Cr
Current Assets ₹6,899.8 Cr ₹7,028.9 Cr ₹5,279.7 Cr ₹4,337.15 Cr
Property, Plant & Equipment ₹11,039 Cr ₹9,815.7 Cr ₹8,540.5 Cr ₹7,432.07 Cr
Inventories ₹542.4 Cr ₹480.8 Cr ₹459.8 Cr ₹390.19 Cr
Trade Receivables ₹3,484.9 Cr ₹3,016.1 Cr ₹2,514.9 Cr ₹2,234.23 Cr
Cash & Equivalents ₹811.3 Cr ₹578.1 Cr ₹505.5 Cr ₹433.42 Cr
Equity (Net Worth) ₹9,974.5 Cr ₹8,652.9 Cr ₹7,320.5 Cr ₹6,531.28 Cr
Equity Share Capital ₹71.9 Cr ₹71.9 Cr ₹71.9 Cr ₹71.89 Cr
Borrowings (Non-current) ₹2,430.1 Cr ₹4,417 Cr ₹2,235.6 Cr ₹1,937.59 Cr
Borrowings (Current) ₹3,228.4 Cr ₹858.2 Cr ₹926.3 Cr ₹772.72 Cr
Total Debt (computed) ₹5,658.5 Cr ₹5,275.2 Cr ₹3,161.9 Cr ₹2,710.31 Cr
Current Liabilities ₹6,481.3 Cr ₹4,578.9 Cr ₹4,664.5 Cr ₹3,324.8 Cr
Total Liabilities ₹12,222 Cr ₹12,005 Cr ₹9,432.6 Cr ₹7,896.45 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹2,855.7 Cr ₹2,136.4 Cr ₹1,920.3 Cr ₹1,377.05 Cr ₹1,615.64 Cr
Investing Cash Flow -₹2,148.2 Cr -₹3,380.6 Cr -₹1,537.1 Cr -₹856.85 Cr -₹790.73 Cr
Financing Cash Flow -₹477.6 Cr ₹1,316.8 Cr -₹311.2 Cr -₹633.33 Cr -₹767.7 Cr
Capital Expenditure ₹1,962 Cr ₹1,712.7 Cr ₹1,136.8 Cr ₹1,128.52 Cr ₹657.17 Cr
Free Cash Flow (computed) ₹893.7 Cr ₹423.7 Cr ₹783.5 Cr ₹248.53 Cr ₹958.47 Cr
Dividends Paid ₹292.8 Cr ₹278.4 Cr ₹220.9 Cr ₹257.92 Cr ₹43.33 Cr
Net Change in Cash ₹229.9 Cr ₹72.6 Cr ₹72 Cr -₹113.13 Cr ₹57.21 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹6,605.5 Cr ₹6,477.4 Cr ₹6,303.5 Cr ₹5,842.1 Cr ₹5,592.2 Cr ₹5,526.9 Cr ₹5,589.3 Cr ₹5,085.6 Cr ₹4,943.9 Cr ₹4,850.6 Cr ₹4,846.9 Cr ₹4,417.8 Cr
Other Income ₹43.9 Cr ₹52.8 Cr ₹54.7 Cr ₹40.2 Cr ₹61.1 Cr ₹63.8 Cr ₹38.2 Cr ₹37.2 Cr ₹28.1 Cr ₹27.8 Cr ₹22.2 Cr ₹28.2 Cr
Total Income ₹6,649.4 Cr ₹6,530.2 Cr ₹6,358.2 Cr ₹5,882.3 Cr ₹5,653.3 Cr ₹5,590.7 Cr ₹5,627.5 Cr ₹5,122.8 Cr ₹4,972 Cr ₹4,878.4 Cr ₹4,869.1 Cr ₹4,446 Cr
Cost of Materials Consumed ₹777.4 Cr ₹744.6 Cr ₹778.7 Cr ₹740.1 Cr ₹694.4 Cr ₹625.6 Cr ₹744.3 Cr ₹690.1 Cr ₹637.5 Cr ₹603.3 Cr ₹632.5 Cr ₹580.8 Cr
Purchases of Stock-in-Trade ₹2,613.1 Cr ₹2,663.1 Cr ₹2,464.7 Cr ₹2,315.5 Cr ₹2,243.6 Cr ₹2,292 Cr ₹2,110.4 Cr ₹1,910.7 Cr ₹1,914.1 Cr ₹1,943.6 Cr ₹1,840.5 Cr ₹1,686.7 Cr
Changes in Inventories ₹11.5 Cr -₹25.3 Cr ₹20 Lakh -₹8 Cr -₹9.4 Cr -₹16.9 Cr ₹3 Cr ₹22.2 Cr -₹5.9 Cr -₹13.8 Cr -₹14.5 Cr ₹70 Lakh
Employee Benefit Expense ₹772 Cr ₹749 Cr ₹766.7 Cr ₹712.6 Cr ₹724.6 Cr ₹686.4 Cr ₹700.1 Cr ₹658.1 Cr ₹644.9 Cr ₹612.9 Cr ₹644.1 Cr ₹591.8 Cr
Finance Costs ₹119.1 Cr ₹112.6 Cr ₹109.6 Cr ₹108.3 Cr ₹114.8 Cr ₹109.8 Cr ₹117.5 Cr ₹116.4 Cr ₹119.3 Cr ₹112.6 Cr ₹111.3 Cr ₹106.2 Cr
Depreciation & Amortisation ₹224.4 Cr ₹219.2 Cr ₹217.8 Cr ₹214.7 Cr ₹211 Cr ₹184.6 Cr ₹184.5 Cr ₹177.4 Cr ₹189.7 Cr ₹167 Cr ₹163.4 Cr ₹166.9 Cr
Other Expenses ₹1,420.5 Cr ₹1,380.7 Cr ₹1,352.1 Cr ₹1,230 Cr ₹1,169.3 Cr ₹1,178.3 Cr ₹1,216 Cr ₹1,129.4 Cr ₹1,112.8 Cr ₹1,090.9 Cr ₹1,116.8 Cr ₹1,048.8 Cr
Total Expenses ₹5,938 Cr ₹5,843.9 Cr ₹5,689.8 Cr ₹5,313.2 Cr ₹5,148.3 Cr ₹5,059.8 Cr ₹5,075.8 Cr ₹4,704.3 Cr ₹4,612.4 Cr ₹4,516.5 Cr ₹4,494.1 Cr ₹4,181.9 Cr
Profit Before Exceptional Items & Tax ₹711.4 Cr ₹686.3 Cr ₹668.4 Cr ₹569.1 Cr ₹505 Cr ₹530.9 Cr ₹551.7 Cr ₹418.5 Cr ₹359.6 Cr ₹361.9 Cr ₹375 Cr ₹264.1 Cr
Exceptional Items ₹0 -₹19.2 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹1.9 Cr ₹0
Profit Before Tax ₹711.4 Cr ₹667.1 Cr ₹668.4 Cr ₹569.1 Cr ₹505 Cr ₹530.9 Cr ₹551.7 Cr ₹418.5 Cr ₹359.6 Cr ₹361.9 Cr ₹376.9 Cr ₹264.1 Cr
Total Tax Expense ₹170.2 Cr ₹165.7 Cr ₹180.7 Cr ₹141.7 Cr ₹101 Cr ₹156.8 Cr ₹161.7 Cr ₹114.5 Cr ₹109.8 Cr ₹108.9 Cr ₹130.2 Cr ₹96.6 Cr
Net Profit ₹551.3 Cr ₹516.3 Cr ₹494 Cr ₹441 Cr ₹414.5 Cr ₹379.4 Cr ₹395.7 Cr ₹315.5 Cr ₹258.4 Cr ₹254.4 Cr ₹248.8 Cr ₹173.4 Cr
  attributable to Owners ₹529.3 Cr ₹502.3 Cr ₹477.2 Cr ₹432.8 Cr ₹389.6 Cr ₹372.3 Cr ₹378.8 Cr ₹305.2 Cr ₹253.8 Cr ₹245.3 Cr ₹232.9 Cr ₹166.6 Cr
  attributable to NCI ₹22 Cr ₹14 Cr ₹16.8 Cr ₹8.2 Cr ₹24.9 Cr ₹7.1 Cr ₹16.9 Cr ₹10.3 Cr ₹4.6 Cr ₹9.1 Cr ₹15.9 Cr ₹6.8 Cr
Other Comprehensive Income -₹4.1 Cr -₹20 Lakh ₹56.8 Cr ₹5.9 Cr -₹3 Cr -₹2.9 Cr -₹5.5 Cr ₹5.2 Cr -₹20 Lakh ₹80 Lakh -₹9.26 Cr -₹1.8 Cr
Total Comprehensive Income ₹547.2 Cr ₹516.1 Cr ₹550.8 Cr ₹446.9 Cr ₹411.5 Cr ₹376.5 Cr ₹390.2 Cr ₹320.7 Cr ₹258.2 Cr ₹255.2 Cr ₹239.54 Cr ₹171.6 Cr
EBITDA (computed) ₹1,054.9 Cr ₹1,018.1 Cr ₹995.8 Cr ₹892.1 Cr ₹830.8 Cr ₹825.3 Cr ₹853.7 Cr ₹712.3 Cr ₹668.6 Cr ₹641.5 Cr ₹649.7 Cr ₹537.2 Cr
Basic EPS ₹36.82 ₹34.94 ₹33.19 ₹30.10 ₹27.10 ₹25.89 ₹26.34 ₹21.23 ₹17.65 ₹17.06 ₹16.20 ₹11.59
Diluted EPS ₹36.76 ₹34.94 ₹33.19 ₹30.10 ₹27.10 ₹25.89 ₹26.34 ₹21.23 ₹17.65 ₹17.06 ₹16.20 ₹11.59
Latest 12 quarters shown of 25 on record.
Segment · Q4 FY26 (latest quarter) Revenue Result (PBIT) Assets Liabilities
Healthcare services ₹3,333.7 Cr ₹614.6 Cr ₹14,486 Cr ₹3,935.7 Cr
Retail health & diagnostics ₹489.5 Cr ₹39.9 Cr ₹1,473.2 Cr ₹1,143.6 Cr
Digital health & pharmacy distribution ₹2,848.2 Cr ₹135.7 Cr ₹3,318.1 Cr ₹946.6 Cr
Others ₹1.3 Cr -₹3.7 Cr ₹25.7 Cr ₹18.3 Cr
Segment · FY 2026 (annual) Revenue Result (PBIT) Assets Liabilities
Healthcare services ₹12,750 Cr ₹2,430.3 Cr - -
Retail health & diagnostics ₹1,865.3 Cr ₹72.3 Cr - -
Digital health & pharmacy distribution ₹10,808 Cr ₹398.7 Cr - -
Others ₹5.2 Cr -₹8.1 Cr - -
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹9,326.2 Cr ₹8,202.1 Cr ₹7,273.8 Cr ₹6,524.84 Cr ₹6,098.33 Cr ₹9,153.04 Cr ₹9,794.43 Cr
Other Income ₹371.8 Cr ₹347.7 Cr ₹179.9 Cr ₹151.51 Cr ₹46.99 Cr ₹18.15 Cr ₹10.91 Cr
Total Income ₹9,698 Cr ₹8,549.8 Cr ₹7,453.7 Cr ₹6,676.35 Cr ₹6,145.32 Cr ₹9,171.19 Cr ₹9,805.34 Cr
Cost of Materials Consumed ₹2,418.8 Cr ₹2,248.4 Cr ₹1,999 Cr ₹1,861.11 Cr ₹1,929.33 Cr ₹1,329.86 Cr ₹1,532.12 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹4,155.2 Cr ₹3,754.19 Cr
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 -₹127.63 Cr -₹104.33 Cr
Employee Benefit Expense ₹1,686.2 Cr ₹1,596.8 Cr ₹1,425.2 Cr ₹1,239.46 Cr ₹1,150.48 Cr ₹1,275.11 Cr ₹1,519.18 Cr
Finance Costs ₹241.7 Cr ₹254 Cr ₹249.8 Cr ₹238.8 Cr ₹244.04 Cr ₹343.8 Cr ₹425.88 Cr
Depreciation & Amortisation ₹500.4 Cr ₹449.4 Cr ₹399 Cr ₹366.69 Cr ₹363.42 Cr ₹435.95 Cr ₹482.26 Cr
Other Expenses ₹2,893.2 Cr ₹2,312.7 Cr ₹2,052.1 Cr ₹1,742.78 Cr ₹1,599.18 Cr ₹1,573.09 Cr ₹1,678.03 Cr
Total Expenses ₹7,740.3 Cr ₹6,861.3 Cr ₹6,125.1 Cr ₹5,448.84 Cr ₹5,286.45 Cr ₹8,985.38 Cr ₹9,287.33 Cr
Profit Before Exceptional Items & Tax ₹1,957.7 Cr ₹1,688.5 Cr ₹1,328.6 Cr ₹1,227.51 Cr ₹858.87 Cr ₹185.81 Cr ₹518.01 Cr
Exceptional Items -₹11.4 Cr ₹0 ₹0 ₹0 -₹6.74 Cr -₹9.09 Cr ₹164.35 Cr
Profit Before Tax ₹1,946.3 Cr ₹1,688.5 Cr ₹1,328.6 Cr ₹1,227.51 Cr ₹852.13 Cr ₹176.72 Cr ₹682.36 Cr
Total Tax Expense ₹453.7 Cr ₹392.2 Cr ₹318.1 Cr ₹142.73 Cr ₹279.79 Cr ₹71.57 Cr ₹212.11 Cr
Net Profit ₹1,492.6 Cr ₹1,296.3 Cr ₹1,010.5 Cr ₹1,084.78 Cr ₹665.03 Cr ₹105.15 Cr ₹470.25 Cr
  attributable to Owners - - - - - - ₹470.25 Cr
Other Comprehensive Income -₹11.6 Cr ₹20 Lakh -₹8.5 Cr -₹11.14 Cr -₹2.24 Cr -₹5.58 Cr ₹75 Lakh
Total Comprehensive Income ₹1,481 Cr ₹1,296.5 Cr ₹1,002 Cr ₹1,073.64 Cr ₹662.79 Cr ₹99.57 Cr ₹471 Cr
EBITDA (computed) ₹2,699.8 Cr ₹2,391.9 Cr ₹1,977.4 Cr ₹1,833 Cr ₹1,466.33 Cr ₹965.56 Cr ₹1,426.15 Cr
Basic EPS ₹103.81 ₹90.15 ₹70.28 ₹75.45 ₹39.81 ₹7.51 ₹33.80
Diluted EPS ₹103.74 ₹90.15 ₹70.28 ₹75.45 ₹39.81 ₹7.51 ₹33.80
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹14,915 Cr ₹13,372 Cr ₹12,405 Cr ₹10,780 Cr
Non-current Assets ₹12,064 Cr ₹9,853.9 Cr ₹8,730.1 Cr ₹7,629.67 Cr
Current Assets ₹2,850.4 Cr ₹3,518.4 Cr ₹3,675.1 Cr ₹3,150.59 Cr
Property, Plant & Equipment ₹6,821.9 Cr ₹6,239 Cr ₹5,970.8 Cr ₹5,049.41 Cr
Inventories ₹146.8 Cr ₹126.6 Cr ₹118.7 Cr ₹98.3 Cr
Trade Receivables ₹847.3 Cr ₹814.8 Cr ₹808.3 Cr ₹819.97 Cr
Cash & Equivalents ₹342.6 Cr ₹233.2 Cr ₹276.1 Cr ₹217.01 Cr
Equity (Net Worth) ₹9,963.2 Cr ₹8,734.2 Cr ₹7,710.9 Cr ₹6,924.74 Cr
Equity Share Capital ₹71.9 Cr ₹71.9 Cr ₹71.9 Cr ₹71.89 Cr
Borrowings (Non-current) ₹1,625 Cr ₹1,553.5 Cr ₹1,785.5 Cr ₹1,520.12 Cr
Borrowings (Current) ₹197.2 Cr ₹229.7 Cr ₹170.2 Cr ₹240.46 Cr
Total Debt (computed) ₹1,822.2 Cr ₹1,783.2 Cr ₹1,955.7 Cr ₹1,760.58 Cr
Current Liabilities ₹1,641.6 Cr ₹1,440.7 Cr ₹1,370.2 Cr ₹1,243.2 Cr
Total Liabilities ₹4,951.3 Cr ₹4,638.1 Cr ₹4,694.3 Cr ₹3,855.52 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹2,059 Cr ₹1,741.9 Cr ₹1,191.4 Cr ₹1,224.23 Cr ₹1,200.87 Cr
Investing Cash Flow -₹1,413 Cr -₹1,045.7 Cr -₹835.3 Cr -₹588.23 Cr -₹444.6 Cr
Financing Cash Flow -₹536.7 Cr -₹739.1 Cr -₹297 Cr -₹778.62 Cr -₹637.22 Cr
Capital Expenditure ₹1,052.9 Cr ₹858.2 Cr ₹621 Cr ₹395.86 Cr ₹462.86 Cr
Free Cash Flow (computed) ₹1,006.1 Cr ₹883.7 Cr ₹570.4 Cr ₹828.37 Cr ₹738.01 Cr
Dividends Paid ₹287.6 Cr ₹273.2 Cr ₹215.7 Cr ₹255.22 Cr ₹43.14 Cr
Net Change in Cash ₹109.3 Cr -₹42.9 Cr ₹59.1 Cr -₹142.62 Cr ₹119.05 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹2,438.5 Cr ₹2,363.7 Cr ₹2,356.1 Cr ₹2,167.9 Cr ₹2,075.3 Cr ₹2,054.8 Cr ₹2,135.4 Cr ₹1,936.6 Cr ₹1,894.6 Cr ₹1,824.3 Cr ₹1,866.5 Cr ₹1,688.4 Cr
Other Income ₹90.3 Cr ₹108 Cr ₹141.1 Cr ₹32.5 Cr ₹91.6 Cr ₹107.9 Cr ₹120.9 Cr ₹27.3 Cr ₹46 Cr ₹51.6 Cr ₹64.6 Cr ₹17.8 Cr
Total Income ₹2,528.8 Cr ₹2,471.7 Cr ₹2,497.2 Cr ₹2,200.4 Cr ₹2,166.9 Cr ₹2,162.7 Cr ₹2,256.3 Cr ₹1,963.9 Cr ₹1,940.6 Cr ₹1,875.9 Cr ₹1,931.1 Cr ₹1,706.2 Cr
Cost of Materials Consumed ₹606.2 Cr ₹611.7 Cr ₹611.2 Cr ₹589.7 Cr ₹562 Cr ₹569.3 Cr ₹580.9 Cr ₹536.2 Cr ₹526.6 Cr ₹496.5 Cr ₹514.2 Cr ₹461.7 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹441.2 Cr ₹410.1 Cr ₹431.2 Cr ₹403.7 Cr ₹410.2 Cr ₹393.5 Cr ₹412.4 Cr ₹380.7 Cr ₹383.9 Cr ₹350.1 Cr ₹357.8 Cr ₹333.4 Cr
Finance Costs ₹63.4 Cr ₹61.7 Cr ₹57.9 Cr ₹58.8 Cr ₹63.1 Cr ₹62 Cr ₹65.4 Cr ₹63.5 Cr ₹68.7 Cr ₹60.6 Cr ₹59.6 Cr ₹60.9 Cr
Depreciation & Amortisation ₹128 Cr ₹126.8 Cr ₹122.4 Cr ₹123.2 Cr ₹129.8 Cr ₹108.4 Cr ₹108.3 Cr ₹102.9 Cr ₹115.3 Cr ₹97.2 Cr ₹93.4 Cr ₹93.1 Cr
Other Expenses ₹795.6 Cr ₹748.4 Cr ₹720.8 Cr ₹628.4 Cr ₹581.8 Cr ₹580.2 Cr ₹601.8 Cr ₹548.9 Cr ₹533.7 Cr ₹527.4 Cr ₹515.4 Cr ₹475.6 Cr
Total Expenses ₹2,034.4 Cr ₹1,958.7 Cr ₹1,943.5 Cr ₹1,803.8 Cr ₹1,746.9 Cr ₹1,713.4 Cr ₹1,768.8 Cr ₹1,632.2 Cr ₹1,628.2 Cr ₹1,531.8 Cr ₹1,540.4 Cr ₹1,424.7 Cr
Profit Before Exceptional Items & Tax ₹494.4 Cr ₹513 Cr ₹553.7 Cr ₹396.6 Cr ₹420 Cr ₹449.3 Cr ₹487.5 Cr ₹331.7 Cr ₹312.4 Cr ₹344.1 Cr ₹390.7 Cr ₹281.5 Cr
Exceptional Items ₹0 -₹11.4 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹494.4 Cr ₹501.6 Cr ₹553.7 Cr ₹396.6 Cr ₹420 Cr ₹449.3 Cr ₹487.5 Cr ₹331.7 Cr ₹312.4 Cr ₹344.1 Cr ₹390.7 Cr ₹281.5 Cr
Total Tax Expense ₹112 Cr ₹118.1 Cr ₹133.8 Cr ₹89.7 Cr ₹86.6 Cr ₹107.7 Cr ₹117.9 Cr ₹80 Cr ₹73.6 Cr ₹81.2 Cr ₹95.9 Cr ₹67.4 Cr
Net Profit ₹382.4 Cr ₹383.5 Cr ₹419.9 Cr ₹306.9 Cr ₹333.4 Cr ₹341.6 Cr ₹369.6 Cr ₹251.7 Cr ₹238.8 Cr ₹262.9 Cr ₹294.8 Cr ₹214.1 Cr
Other Comprehensive Income -₹6.8 Cr -₹2.4 Cr -₹8.1 Cr ₹5.7 Cr ₹10 Lakh -₹2.5 Cr -₹2.4 Cr ₹5 Cr ₹30 Lakh ₹80 Lakh -₹8 Cr -₹1.6 Cr
Total Comprehensive Income ₹375.6 Cr ₹381.1 Cr ₹411.8 Cr ₹312.6 Cr ₹333.5 Cr ₹339.1 Cr ₹367.2 Cr ₹256.7 Cr ₹239.1 Cr ₹263.7 Cr ₹286.8 Cr ₹212.5 Cr
EBITDA (computed) ₹685.8 Cr ₹701.5 Cr ₹734 Cr ₹578.6 Cr ₹612.9 Cr ₹619.7 Cr ₹661.2 Cr ₹498.1 Cr ₹496.4 Cr ₹501.9 Cr ₹543.7 Cr ₹435.5 Cr
Basic EPS ₹26.59 ₹26.67 ₹29.20 ₹21.35 ₹23.18 ₹23.76 ₹25.71 ₹17.51 ₹16.61 ₹18.28 ₹20.50 ₹14.89
Diluted EPS ₹26.56 ₹26.67 ₹29.20 ₹21.35 ₹23.18 ₹23.76 ₹25.71 ₹17.51 ₹16.61 ₹18.28 ₹20.50 ₹14.89
Latest 12 quarters shown of 24 on record.
Segment · FY 2022 (annual) Revenue Result (PBIT) Assets Liabilities
Others ₹0 ₹0 - -
healthcare ₹6,099.83 Cr ₹1,055.92 Cr - -
Want more history and ratios?
You're viewing the latest exchange-filed financials for Apollo Hospitals Enterprise Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Apollo Hospitals Enterprise Limited

As per the shareholding pattern filed with NSE for the quarter ended Jun 2026, promoters hold 28.02%, foreign institutional investors hold 41.50%, domestic institutional investors hold 23.72%, retail and other public shareholders hold 6.54% of Apollo Hospitals Enterprise Limited. The company had 174,281 shareholders on record.

Promoters: 28.02%DII (Domestic Institutional): 23.72%FII (Foreign Institutional): 41.50%Retail & Others: 6.54%
Jun 2026
QUARTER
28.02% Promoters
23.72% DII (Domestic Institutional)
41.50% FII (Foreign Institutional)
6.54% Retail & Others
Promoter holding - history
Now 28.02% · Jun 2026High 34.40% · Jun 2018Low 28.02% · Sep 2025
27%29.3%31.5%33.8%36%Dec 2015Jun 2018Dec 2020Mar 2023Sep 2025Dec 2015: 34.35%Mar 2016: 34.35%Jun 2016: 34.35%Sep 2016: 34.35%Dec 2016: 34.35%Mar 2017: 34.35%Jun 2017: 34.35%Sep 2017: 34.38%Dec 2017: 34.38%Mar 2018: 34.39%Jun 2018: 34.40%Sep 2018: 34.40%Dec 2018: 34.40%Mar 2019: 34.40%Jun 2019: 34.40%Sep 2019: 30.80%Dec 2019: 30.80%Mar 2020: 30.81%Jun 2020: 30.82%Sep 2020: 30.82%Dec 2020: 30.82%Jan 2021: 29.81%Mar 2021: 29.82%Jun 2021: 29.82%Sep 2021: 29.82%Dec 2021: 29.33%Mar 2022: 29.33%Jun 2022: 29.33%Sep 2022: 29.33%Dec 2022: 29.33%Mar 2023: 29.33%Jun 2023: 29.33%Sep 2023: 29.33%Dec 2023: 29.33%Mar 2024: 29.33%Jun 2024: 29.33%Sep 2024: 29.33%Dec 2024: 29.33%Mar 2025: 29.34%Jun 2025: 29.34%Sep 2025: 28.02%Dec 2025: 28.02%Mar 2026: 28.02%Jun 2026: 28.02%34.40%28.02%28.02%
Shareholding trend - last 6 quarters
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
Promoters28.02%28.02%28.02%28.02%29.34%29.34%
Public71.98%71.98%71.98%71.98%70.66%70.66%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters28.02%29.34%29.33%29.33%29.33%29.82%30.81%34.40%34.39%34.35%34.35%
Public71.98%70.66%70.67%70.67%70.67%70.18%69.19%65.60%65.61%65.65%65.65%
Promoter change (YoY, %pts)-1.32+0.01+0.00+0.00-0.49-0.99-3.59+0.01+0.04+0.00-

Board & Governance of Apollo Hospitals Enterprise Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Apollo Hospitals Enterprise Limited has 10 directors - 5 independent and 4 executive. The board is chaired by PRATAP C REDDY.

DirectorPositionOn board sinceListed boards
PRATAP C REDDY Executive Director · Chairperson 1979-12-05 2
PREETHA REDDY Executive Director 1989-02-03 3
SUNEETA REDDY Executive Director · MD 2000-05-01 4
SHOBANA KAMINENI Non-Executive - Non Independent Director 2010-02-01 1
SANGITA REDDY Executive Director 2000-07-31 3
PUDUGRAMAM MURALI DORAISWAMY Non-Executive - Independent Director 2018-09-27 1
MANDAVILLI BHASKARA NAGESWARA RAO Non-Executive - Independent Director 2019-02-09 1
VELAGAPUDI KAVITHA V DUTT Non-Executive - Independent Director 2019-02-09 4
SOM MITTAL Non-Executive - Independent Director 2021-07-21 3
RAMA BIJAPURKAR Non-Executive - Independent Director 2021-11-12 4
Board Committees
CommitteeMembers
Audit Committee MANDAVILLI BHASKARA NAGESWARA RAO (Chairperson), VELAGAPUDI KAVITHA V DUTT, SOM MITTAL
Nomination and remuneration committee PUDUGRAMAM MURALI DORAISWAMY (Chairperson), MANDAVILLI BHASKARA NAGESWARA RAO, RAMA BIJAPURKAR
Stakeholders Relationship Committee VELAGAPUDI KAVITHA V DUTT (Chairperson), PREETHA REDDY, SUNEETA REDDY
Risk Management Committee SUNEETA REDDY (Chairperson), PREETHA REDDY, VELAGAPUDI KAVITHA V DUTT, DR MADHU SASIDHAR, DR ROHINI SRIDHAR
Corporate Social Responsibility Committee PRATAP C REDDY (Chairperson), PREETHA REDDY, SUNEETA REDDY, SANGITA REDDY, MANDAVILLI BHASKARA NAGESWARA RAO, PUDUGRAMAM MURALI DORAISWAMY
INVESTMENT COMMITTEE MANDAVILLI BHASKARA NAGESWARA RAO (Chairperson), PUDUGRAMAM MURALI DORAISWAMY, PREETHA REDDY, SUNEETA REDDY, VELAGAPUDI KAVITHA V DUTT

Group Structure of Apollo Hospitals Enterprise Limited

Apollo Hospitals Enterprise Limited has 34 subsidiary companies, 2 joint ventures, and 3 associated companies. This group structure data is as of FY 2024. The corporate group structure reflects Apollo Hospitals Enterprise Limited's business expansion strategy and organizational complexity.

34
Subsidiary companies
2
Joint ventures
3
Associated companies
Key Subsidiaries
Company Name CIN Shares Held
Apollo Multispeciality Hospitals Limited U33112WB1988PLC045223 -
Future Parking Private Limited U45206TN2009PTC072304 -
Health Axis Private Limited U62099TN2023PTC161547 -
Ahll Risk Management Private Limited U66000TG2018PTC125224 -
Sobhagya Hospital And Research Centre Private Limited U68100MP1992PTC007118 -
Sapien Biosciences Private Limited U73100TG2012PTC080254 -

Showing major subsidiaries. Total: 34.

Charges & Borrowings of Apollo Hospitals Enterprise Limited

Open charges
₹3,978.73 Cr
Satisfied charges
₹5,997.95 Cr
Breakdown by lending institutions
State Bank of India₹1,150.00 Cr
Bank of India₹800.00 Cr
Hdfc Bank Limited₹700.00 Cr
Axis Bank Limited₹650.00 Cr
The Hongkong and Shanghai Banking Corporation Limited₹350.00 Cr
Others₹328.73 Cr
Latest charge details
DateLenderAmountStatus
04 Mar 2026 Bank of India ₹500 Cr Open
31 May 2023 State Bank of India ₹350 Cr Open
03 Sep 2021 Others ₹200 Cr Open
16 Jul 2021 Bank of India ₹300 Cr Open
01 Jun 2021 Axis Bank Limited ₹500 Cr Open

Total charge records: 110 View all charges

Employees and EPFO Compliance at Apollo Hospitals Enterprise Limited

Apollo Hospitals Enterprise Limited has a workforce of 24,811 employees as of Feb 03, 2026.

Employee count
24,811
Active EPFO establishments
28
Employee growth
-0.45%
Premium access

Employee and EPFO history for Apollo Hospitals Enterprise Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Apollo Hospitals Enterprise Limited

Premium access

GST registrations and filing compliance for Apollo Hospitals Enterprise Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Apollo Hospitals Enterprise Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Apollo Hospitals Enterprise Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Apollo Hospitals Enterprise Limited

Premium access

MSME payment history for Apollo Hospitals Enterprise Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Apollo Hospitals Enterprise Limited

Premium access

Corporate group structure for Apollo Hospitals Enterprise Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Apollo Hospitals Enterprise Limited

Premium access

MCA filings and documents for Apollo Hospitals Enterprise Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Apollo Hospitals Enterprise Limited

Charges
04 Mar 2026
A charge with Bank Of India amounted to Rs. 500.00 Cr with Charge ID 101263222 was registered on 04 Mar 2026.
Charges
23 Jan 2026
A charge with State Bank Of India of Rs. 350.00 Cr registered on 31 May 2023 with Charge ID 100727579 was modified on 23 Jan 2026.
Charges
25 Nov 2025
A charge with Axis Bank Limited of Rs. 500.00 Cr registered on 01 Jun 2021 with Charge ID 100451503 was modified on 25 Nov 2025.
Activity
29 Aug 2025
Apollo Hospitals Enterprise Limited last Annual general meeting of members was held on 29 Aug 2025 as per latest MCA records.
Charges
29 Jul 2025
A charge registered on 18 Mar 2016 via Charge ID 100020754 with Others was fully satisfied on 29 Jul 2025.
Activity
31 Mar 2025
Apollo Hospitals Enterprise Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.

Frequently Asked Questions about Apollo Hospitals Enterprise Limited

Apollo Hospitals Enterprise Limited is an active public limited company in the healthcare sector based in Chennai, Tamil Nadu, India. It was incorporated on 05 December 1979 (47+ years old) and is registered under CIN L85110TN1979PLC008035. Listed on BSE: 508869 and NSE: APOLLOHOSP. The company has 24,811 employees.

Apollo Hospitals Enterprise Limited reported revenue of ₹25,229 Cr for FY 2026 (up 15.76% YoY) based on consolidated NSE filings.

The current directors of Apollo Hospitals Enterprise Limited are:

The primary industry of Apollo Hospitals Enterprise Limited is healthcare. The company specifically operates in hospitals. The company is currently active in this sector.

Yes. Apollo Hospitals Enterprise Limited is listed on both BSE (code: 508869) and NSE (symbol: APOLLOHOSP).

Apollo Hospitals Enterprise Limited can be reached at the registered office: 19 Bishop Gardens R A Puram, Chennai, Tamil Nadu, India – 600028, or through the website apollohospitals.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available